Frontotemporal dementia and potential therapeutics

Fiona Kumfor, Sandra Baez, Agustin Ibañez

Producción científica: Capítulo del libro/informe/acta de congresoCapítulorevisión exhaustiva

Resumen

Frontotemporal dementia is the second most common younger-onset dementia affecting people under age 65 after Alzheimer’s disease. Here, we review the clinical, cognitive, neuroimaging and pathological profiles in the main subtypes of frontotemporal dementia: behavioral-variant frontotemporal dementia and primary progressive aphasia, which is further subdivided into semantic dementia, progressive nonfluent aphasia and logopenic progressive aphasia. While no disease-modifying treatments have yet been discovered, several symptomatic treatments are currently in use, with variable efficacy. In this chapter we consider the available pharmacological, behavioral, cognitive and carer interventions which have been investigated in frontotemporal dementia. We focus specifically on the types of patients likely to benefit from these interventions and known contraindications for their use. Finally we highlight the importance of accurate diagnosis and clear clinicopathological associations to facilitate the development of effective therapies in this disorder. While unfortunately the management of this devastating condition is currently challenging, a surge of research into frontotemporal dementia over the past two decades offers hope for improved treatment on the horizon.

Idioma originalInglés
Título de la publicación alojadaResearch Progress in Alzheimer’s Disease and Dementia. Volume 6
EditorialNova Science Publishers, Inc.
Páginas129-168
Número de páginas40
ISBN (versión digital)9781634852067
ISBN (versión impresa)9781634851725
EstadoPublicada - 1 ene. 2016

Huella

Profundice en los temas de investigación de 'Frontotemporal dementia and potential therapeutics'. En conjunto forman una huella única.

Citar esto